Long-term follow-up of patients with systemic AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation after induction and mobilisation chemotherapy

被引：0
|
作者：
Schonland, S. O. [1 ]
Bochtler, T. [1 ]
Hansberg, M. [1 ]
Mangatter, A. [1 ]
Perz, J. B. [1 ]
Ho, A. D. [1 ]
Goldschmidt, H. [1 ]
Hegenbart, U. [1 ]
机构：
[1] Univ Heidelberg, Heidelberg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [1] LONGTERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS TREATED WITH HIGH-DOSE MELPHALAN AFTER INDUCTION AND MOBILIZATION CHEMOTHERAPY
    Schonland, S. O.
    Bochtler, T.
    Hansberg, M.
    Mangatter, A.
    Perz, J. B.
    Hundemer, M.
    Ho, A. D.
    Goldschmidt, H.
    Hegenbart, U.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 36 - 36
  • [2] Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation
    Chockalingam, Ramya
    Duvic, Madeleine
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (10) : E539 - E543
  • [3] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    Perz, JB
    Rahemtulla, A
    Giles, C
    Szydlo, RM
    Davis, J
    Gopaul, D
    Gillmore, J
    Mathias, CJ
    Hawkins, PN
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 937 - 943
  • [4] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    J B Perz
    A Rahemtulla
    C Giles
    R M Szydlo
    J Davis
    D Gopaul
    J Gillmore
    C J Mathias
    P N Hawkins
    J F Apperley
    Bone Marrow Transplantation, 2006, 37 : 937 - 943
  • [5] Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation
    Gupta, Aarti
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (01) : 49 - 52
  • [6] Long-term follow-up in patients with multiple sclerosis after high-dose chemotherapy and autologous stem cell transplantation
    Shevchenko, Y
    Novik, A
    Afanasiev, B
    Ionova, T
    Lisukov, I
    Kulagin, A
    Malysheva, O
    Bisaga, G
    Melnichenko, V
    Fedorenko, D
    Vereschagina, I
    Voloshin, S
    Chelombit, L
    Kishtovich, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S30 - S31
  • [7] LONG-TERM RESULTS OF 174 PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS TREATED WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
    Hegenbart, U.
    Bochtler, T.
    Dreger, P.
    Kimmich, C.
    Ziehl, R.
    Goldschmidt, H.
    Ho, A.
    Schoenland, S.
    HAEMATOLOGICA, 2014, 99 : 504 - 504
  • [8] High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis
    Perz, JB
    Schoenland, S
    Hundemer, M
    Linke, RP
    Ho, AD
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S159 - S159
  • [9] Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis
    Gupta, Vishal K.
    Brauneis, Dina
    Shelton, Anthony C.
    Quillen, Karen
    Sloan, John Mark
    Sanchorawala, Vaishali
    BLOOD, 2018, 132
  • [10] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
12345